TenNor Therapeutics (Suzhou) Limited (HKG:6872)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
202.00
-1.60 (-0.79%)
Jun 1, 2026, 4:08 PM HKT

HKG:6872 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Selling, General & Admin
48.9113.1419.39
Research & Development
71.8769.84108.4
Other Operating Expenses
-1.63-4.96-4.59
Operating Expenses
119.1678.01123.2
Operating Income
-119.16-78.01-123.2
Interest Expense
-1.48-1.89-2.35
Interest & Investment Income
0.660.250.47
Other Non Operating Income (Expenses)
-33.76-66.29-67.49
EBT Excluding Unusual Items
-153.73-145.94-192.56
Gain (Loss) on Sale of Investments
0.490.010.72
Pretax Income
-153.24-145.93-191.84
Net Income
-153.24-145.93-191.84
Net Income to Common
-153.24-145.93-191.84
Shares Outstanding (Basic)
403837
Shares Outstanding (Diluted)
403837
Shares Change (YoY)
6.21%1.54%-
EPS (Basic)
-3.85-3.89-5.19
EPS (Diluted)
-3.85-3.89-5.19
Free Cash Flow
-87.42-48.8-98.51
Free Cash Flow Per Share
-2.19-1.30-2.67
EBITDA
-118.66-76.42-121.6
D&A For EBITDA
0.51.591.6
EBIT
-119.16-78.01-123.2